Qiaobing Xu is the founder of Hopewell Therapeutics. Hopewell Therapeutics has raised $49M in total funding. Latest round: Seed.
Qiaobing Xu, PhD, is the founder of Hopewell Therapeutics, a Boston-based company. He currently serves as the Founder and Interim CEO, and his work at Hopewell Therapeutics focuses on developing next-generation tissue-targeting lipid nanoparticles for drug delivery and cancer vaccines. The company leverages proprietary ttLNPs licensed from Tufts University.
Full founder directory · Investor directory · Company funding database · Fundraising library